Amundi

SEC CIK: 0001330387
Latest filing: Aug 26, 2026

SEC filings (opens in a new tab)

VNDA holding history

Vanda Pharmaceuticals Inc. in every 13F filed by Amundi, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

VNDA overview All 13F holders of VNDA Full Q2 2026 holdings

Shares (Q3 2023): 0; Sold out in Q3 2023
Value: $0
% of portfolio: 0.0%
Quarters held: 2; Since Q1 2023

Holdings of VNDA by Amundi, by quarter
Quarter	Shares	Value	% of portfolio	Share change	Action	All holders
Q3 2023	0	$0	0.0%	−7,825−100.0%	Sold out	Holders
Q2 2023	7,825	$50.3K	<0.1%	+124+1.6%	Added	Holders
Q1 2023	7,701	$52.0K	<0.1%	+7,701	New	Holders